Lixte Biotechnology (LIXT) Stock Chart & Stock Price History $1.27 +0.06 (+4.77%) As of 01:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lixte Biotechnology Stock Price Performance The Lixte Biotechnology (LIXT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 50.23%, with a year-to-date return of -37.24%. In the past month, the stock has increased 5.38%, reflecting recent market activity. As of the latest close, Lixte Biotechnology traded at $1.22 with a market cap of $3.83 million and volume of 10,918 shares. Five years ago, the stock traded at a split-adjusted price of $9.00, representing a 85.84% decrease over that period. At the time, it had a market cap of $0.00 and a volume of 137 shares. Receive LIXT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.97%1 Month Performance+5.38%3 Month Performance-25.06%6 Month Performance-24.17%Year-To-Date Performance-37.24%1 Year Performance-50.23%3 Year Performance-86.21%5 Year Performance-85.84% LIXT Stock Chart for Monday, May, 12, 2025 LIXT Chart by TradingView Lixte Biotechnology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/09/2025$1.24$1.22-2.25%$1.28$1.2110,918 shs$3.83 million05/08/2025$1.19$1.24+4.45%$1.23$1.214,241 shs$3.92 million05/07/2025$1.18$1.19+0.93%$1.28$1.156,424 shs$3.75 million05/06/2025$1.27$1.18-7.09%$1.31$1.159,090 shs$3.72 million05/05/2025$1.25$1.27+1.60%$1.28$1.252,497 shs$4.00 million05/02/2025$1.26$1.25-0.79%$1.26$1.149,239 shs$3.94 million05/01/2025$1.26$1.26$1.32$1.262,176 shs$3.97 million04/30/2025$1.29$1.26-2.02%$1.29$1.242,615 shs$3.97 million04/29/2025$1.39$1.29-7.15%$1.34$1.287,841 shs$4.05 million04/28/2025$1.28$1.39+8.20%$1.37$1.287,045 shs$4.36 million Get the Latest News and Ratings for LIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 04/25/2025$1.26$1.28+1.91%$1.31$1.241,890 shs$4.03 million04/24/2025$1.30$1.26-3.38%$1.50$1.2222,240 shs$3.96 million04/23/2025$1.17$1.30+11.11%$1.35$1.1732,686 shs$4.10 million04/22/2025$1.24$1.17-5.65%$1.23$1.1018,506 shs$3.69 million04/21/2025$1.20$1.24+3.33%$1.24$1.136,114 shs$3.91 million04/18/2025$1.20$1.20$1.22$1.13458 shs$3.78 million04/17/2025$1.23$1.20-2.12%$1.22$1.13458 shs$3.78 million04/16/2025$1.27$1.23-3.39%$1.28$1.223,798 shs$3.86 million04/15/2025$1.19$1.27+6.64%$1.30$1.164,548 shs$4.00 million04/14/2025$1.21$1.19-1.57%$1.26$1.191,091 shs$3.75 million04/11/2025$1.13$1.21+6.99%$1.25$1.156,196 shs$3.81 million Related Companies LPTX Stock Price Chart GELS Stock Price Chart COCP Stock Price Chart TRIB Stock Price Chart MBRX Stock Price Chart BCTX Stock Price Chart EQ Stock Price Chart NRSN Stock Price Chart GOVX Stock Price Chart MRKR Stock Price Chart Receive LIXT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lixte Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LIXT) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredVIDEO: Strange New Elon Device to Shock the WorldElon Musk’s Next BIG Bet And this time he plans to dominate a market worth $3.2 trillion. That’s why I’m...Banyan Hill Publishing | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThis picture could hold the secret to the market's next move.A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.